# NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ny-eso-1-is-a-ubiquitous-immunotherapeutic-target-antigen-for-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Seth M. Pollack,Achim A. Jungbluth,Benjamin Hoch,Erik Farrar,Marie Bleakley,David J. Schneider,Elizabeth T. Loggers,Eve T. Rodler,Janet F. Eary,Ernest U. Conrad,Robin L. Jones,Cassian Yee |
| Citations | 123 |
| DOI | 10.1002/cncr.27446 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1572718168 |
| PMID | 22359263 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Seth M. Pollack](https://scholariq.org/researchers/seth-m-pollack/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Paper topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.